Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Centessa Pharmaceuticals (CNTA) Receivables - Other (2024 - 2025)

Historic Receivables - Other for Centessa Pharmaceuticals (CNTA) over the last 2 years, with Q3 2025 value amounting to $1.9 million.

  • Centessa Pharmaceuticals' Receivables - Other changed N/A to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year change of. This contributed to the annual value of $287000.0 for FY2024, which is N/A changed from last year.
  • Centessa Pharmaceuticals' Receivables - Other amounted to $1.9 million in Q3 2025.
  • In the past 5 years, Centessa Pharmaceuticals' Receivables - Other ranged from a high of $2.2 million in Q2 2025 and a low of $287000.0 during Q4 2024